Our Small Molecule division is focused on leveraging its technologies and expertise to address solubility challenges and support drug development programs through commercialization. Download our e-book to learn about the importance of patient-centric formulations. Discover how evaluating formulation approaches ensures the best option for the product, considering the target product profile, patient population and properties of the API.
In this e-book, you will find:
- The advantages of multiparticulate formulations, especially for pediatric patients
- Methods for improving the bioavailability of poorly soluble APIs
- Information on how the MSAT (Manufacturing, Science, and Technology) team supports late-stage process development and scale-up, commercial process validation, and process lifecycle management